花園生物(300401.SZ):全資子公司簽訂《非住宅房屋搬遷補償協議》 搬遷補償金額合計2.71億元
格隆匯 8 月 24日丨花園生物(300401.SZ)公告,因杭州市錢塘新區城市有機更新工作需要,公司全資子公司杭州下沙生物科技有限公司(以下簡稱“下沙生物”)、杭州洛神科技有限公司(以下簡稱“洛神科技”)與杭州錢塘新區城市有機更新指揮部辦公室簽訂了《非住宅房屋搬遷協議》,涉及下沙生物、洛神科技的搬遷及土地收回等事項。
根據《公司章程》、《深圳證券交易所股票上市規則》規定,本次事項不構成關聯交易,不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。2020年8月24日,公司召開的第五屆董事會第二十一次會議審議了《關於公司全資子公司簽訂<非住宅房屋搬遷補償協議>的議案》。
下沙生物與洛神科技本次搬遷補償金額合計人民幣2.71億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.